Kinfo
Artivion Inc. logo

Artivion Inc.

AORTNYSEHealthcare·US · USD
$24.09
-0.02 (-0.08%)
Prices as of July 10, 2026 · market closed

Price

Key statistics

Valuation
Market cap1.17B USD
Enterprise value1.37B USD
Trailing P/E92.73
Forward P/E33.49
PEG ratio-0.23
Price / sales2.55
Price / book2.60
Profitability
Gross margin64.85%
Operating margin5.18%
Profit margin2.55%
Return on assets2.84%
Return on equity3.14%
Income (TTM)
Revenue458.69M USD
Gross profit296.10M USD
EBITDA60.72M USD
Net income11.68M USD
Diluted EPS$0.26
Rev. growth (YoY)17.50%
Balance sheet
Total cash55.76M USD
Total debt258.16M USD
Debt / equity57.31
Current ratio3.86
Book value / share$9.29
Cash flow (TTM)
Operating cash flow57.99M USD
Levered free cash flow-7.29M USD
Shares & price
Shares outstanding48.50M
Float45.97M
Held by institutions92.84%
Beta1.25
50-day MA$24.37
200-day MA$37.12
52-week high$48.25
52-week low$19.16
Dividends
Forward rate
$0.12
Yield
0.50%
Payout ratio
0.00%
Frequency
Quarterly
Recent payments
  • 2015-12-09$0.03
Earnings (EPS)
DateEst.ActualSurprise2026-06-090.480.22−54.17%2026-05-040.780.87+11.54%2026-04-10-0.16-0.14+12.50%2026-03-30-0.65-0.68−4.62%
About Artivion Inc.

Artivion Inc. is a medical device company focused on providing innovative technology solutions aimed at improving patient outcomes. Its primary function is to develop, manufacture, and sell devices associated with cardiac and vascular surgery, with a particular emphasis on cryopreservation and heart valve structures. The company's product portfolio serves critical areas such as aortic repair, heart valve therapy, and advanced cryogenic preservation techniques, underpinning its vital presence in the cardiovascular treatment sector. Its products are essential in supporting cardiac surgeons and healthcare professionals in utilizing life-saving technologies during complex medical procedures. Artivion Inc. serves a global market, impacting numerous aspects of healthcare by enabling the treatment of complex heart conditions and elevating surgical efficiency and efficacy. Headquartered in the United States, the company continues its commitment to innovation and quality in medical technology, playing a crucial role in advancing health outcomes and directly contributing to the fields of cardiovascular surgery and transplant medicine.

Sector
Healthcare
Industry
Medical Devices
CEO
Mr. James Patrick Mackin
Employees
1,600
Headquarters
Kennesaw, GA, United States

Frequently asked questions about Artivion Inc.